Evidence map›Paper›PMID 36749386›Full record

ArticleJournal of gastroenterology2023

Further notice of omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.

Yukari Tanaka, Riu Yamashita, Junko Kawashima, Hiroshi Mori, Ken Kurokawa, Shinji Fukuda, Yasuhiro Gotoh, Keiji Nakamura, Tetsuya Hayashi, Yoshiyuki Kasahara and 2 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Yukari Tanaka *Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Japan.
Riu Yamashita *Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
Junko KawashimaTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Hiroshi MoriAdvanced Genomics Center, National Institute of Genetics, Shizuoka, Japan.
Ken KurokawaAdvanced Genomics Center, National Institute of Genetics, Shizuoka, Japan.
Shinji FukudaInstitute for Advanced Biosciences, Keio University, Yamagata, Japan.
Yasuhiro GotohDepartment of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Keiji NakamuraDepartment of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tetsuya HayashiDepartment of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshiyuki KasaharaDepartment of Fetal and Maternal Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yukuto SatoCenter for Strategic Research Project, University of the Ryukyus, Nishihara, Okinawa, Japan.
Shin FukudoBehavioral Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. sfukudo@med.tohoku.ac.jp.ORCID 0000-0003-2265-0349

Funding

AMED-CREST JP21gm1010009JSPS KAKENHI 16H06279 (PAGS)JSPS KAKENHI 17K17584JSPS KAKENHI 19K22589JSPS KAKENHI JST ERATO JPMJER1902JSPS KAKENHI SRF
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Irritable Bowel SyndromeMicrobiotaDiarrheaFecal Microbiota TransplantationFecesHumansSymptom Flare Up

Identifiers

PMID36749386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.